Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Device Design & Manufacturing

See what CB Insights has to offer


Unattributed | Alive

Total Raised


Last Raised

$50K | 8 yrs ago

About Sun Diagnostics

Sun Diagnostics strives to identify and develop new products for the in vitro diagnostic (IVD) industry that will contribute to the advancement of laboratory medicine and improve healthcare. The company's focus is on innovative products that meet the needs of patients, clinicians, laboratories, and researchers.

Sun Diagnostics Headquarter Location

60 Pineland Drive Auburn Hall, Suite 305

New Gloucester, Maine, 04260,

United States


Latest Sun Diagnostics News

Sun Diagnostics LLC Continues to Simplify Interference Testing with the Release of ASSURANCE Drug Interference Test Kit

Sep 30, 2014

Testing for reproductive interference in the population dynamics of two congeneric species of herbivorous mites Manufacturers and clinical laboratories are doing a reasonably good job assessing endogenous interferents that may alter lab test results. The next big hurdle is the assessment of interference from common drugs. There are literally hundreds of drugs in clinical use, both prescription and over-the-counter, which can vary widely in their blood and urine concentrations and which can introduce errors in laboratory testing. Which are the most important to test? An expert panel was convened to make specific recommendations concerning the drugs and concentrations that should be assessed when validating laboratory tests.1 Preparing concentrated drug solutions for interference testing has been labor intensive and expensive - until now. Sun Diagnostics now offers ASSURANCE™ DRUG Interference Test Kit for Laboratory Use as part of interference testing procedures. Interferents available include: ACETAMINOPHEN, N-ACETYLCYSTEINE, ACETYLSALICYLIC ACID, AMPICILLIN SODIUM, CEFOXITIN SODIUM, CYCLOSPORINE, DOXYCYCLINE HCL, HEPARIN, IBUPROFEN, LEVODOPA, METHYLDOPA, METRONIDAZOLE, PHENYLBUTAZONE, RIFAMPICIN, and THEOPHYLLINE. Components may be purchased individually, in customer-defined combinations, or as INT-04 (one vial of each component). Drug components and concentrations are based on recommendations by the expert panel1 and the Clinical Laboratory Standards Institute (CLSI).2 The concentrations are 20 times the recommended test concentrations, allowing a 1:20 dilution with serum/urine pool. Drugs included are acetylcysteine, ampicillin Na, cefoxitin Na, doxycycline HCl, theophylline, levodopa, methyldopa, metronidazole, acetylsalicylic acid, ibuprofen, phenylbutazone, rifampicin, cyclosporine, acetaminophen and heparin, all at 20X concentrations.  

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.